Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion type Assertion NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_head.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion evidence source_evidence_literature NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion SIO_000772 16645590 NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion wasDerivedFrom befree-20150227 NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.
- NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_assertion wasGeneratedBy ECO_0000203 NP622902.RANln3Ey9fhF2BeS2mJQM1NfZCpDQIzk6FM38PSWISqxE130_provenance.